• 14536 Citations
  • 64 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jan Craig Buckner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Glioma Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Astrocytoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2019

Alliance NCORP Research Base

Buckner, J. C., Paskett, E. D. & Paskett, E. D.

National Institutes of Health

8/1/147/31/19

Project: Research project

Research
Clinical Trials
Research Personnel
Neoplasms
Translational Medical Research
Neoplasms
Translational Medical Research
Therapeutics
Technology
Circulating Neoplastic Cells

Mayo SPORE in Brain Cancer

Loftus, J. C., Anastasiadis, P. Z., Galanis, E., Buckner, J. C., Sarkaria, J. N., Giannini, C., Ballman, K. V., Yang, P., James, C. D., O'Neill, B. P. P., O'Neill, B. P., Uhm, J., O'Neill, B. P. & Uhm, J.

National Institutes of Health

9/20/048/31/16

Project: Research project

Glioma
Brain Neoplasms
Glioblastoma
Measles virus
Research

NORTH CENTRAL CANCER TREATMENT GROUP

Witzig, T. E., Sloan, J. A., Erlichman, C., Buckner, J. C., Moertel, C. G., Perez, E. A., Moertel, C. G., Pearson, J., Roche, P., Quella, S., O'Fallon, J., Brindle, J., Itzkowitz, F., Jett, J., Goldberg, R., Steiner, S., Hatfield, A., Weiland, T., O'Connell, M. & Moertel, C. G.

National Institutes of Health

1/1/8212/31/14

Project: Research project

Neoplasms
Therapeutics
Translational Medical Research
Research
Quality of Life

CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)

David, C. S., Jenkins, R. B., Cunningham, J. M., Wettstein, P. J., Buckner, J. C., Lingle, W. L., Kocher, J., Highsmith, W. E. J., Beebe, T. J., Vile, R. G., Okuno, S. H., Sarkaria, J. N., Alberts, S. R., Salisbury, J. L., Van Deursen, J., Diasio, R. B., Sargent, D. J., Thibodeau, S. N., Ingle, J. N., Reid, J. M., Colon-Otero, G., Galanis, E., Weinshilboum, R. M., Jenkins, R. B., Banks, P., Flotte, T., Kwon, E. D., Federspiel, M. J., Pitot, H. C., Dewald, G., Held, K., Liebson, P., Banks, P., Prendergast, F., Weiland, L., Wiebeu, E., Moertel, C., Clapham, D., Burnham, N., O'Connell, M., Spelsburg, T., Maihle, N., Katzmann, J., Wieand, H., Kovach, J., Wold, L., Grendahl, D., McCormick, D., Leibson, P., O'Fallon, J., Ames, M., Kline, B., Prendergast, F., Adjei, A., Chute, C., McKean, D., Highsmith, E., Raghavakaimal, S., Pitot, H., Greipp, P., Wieben, E., Roche, P., Leibson, P., Lawson, M., Grendahl, D., McCormick, D., Ames, M., Wieben, E. D., Flotte, T. J., Adjei, A. & Greipp, P. T.

National Institutes of Health

3/1/802/28/19

Project: Research project

Neoplasms
Research
Research Personnel
Cytogenetics
Biostatistics

Research Output 1988 2019

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., Jeyapalan, S. A., Anderson, D. M., Kaufmann, T. J., Feathers, R. W., Giannini, C., Buckner, J. C., Anastasiadis, P. Z. & Schiff, D., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Glioblastoma
Placebos
Neoplasms
Therapeutics
National Cancer Institute (U.S.)

Controversies in the Therapy of Low-Grade Gliomas

Carabenciov, I. D. & Buckner, J. C., Apr 1 2019, In : Current treatment options in oncology. 20, 4, 25.

Research output: Contribution to journalReview article

Glioma
Neoplasms
Alkylating Agents
Therapeutics
Radiotherapy
Open Access
Oligodendroglioma
Astrocytoma
Names
Publications
Neoplasms

Neuro-oncology clinical debate: Pcv or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma

Ruff, M. W., Buckner, J. C., Johnson, D. R., Van Den Bent, M. J. & Geurts, M., Jan 30 2019, In : Neuro-Oncology Practice. 6, 1, p. 17-21 5 p.

Research output: Contribution to journalArticle

temozolomide
Oligodendroglioma
Medical Oncology
Lomustine
Radiation

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R. B., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Astrocytoma
Neoplasms
Therapeutics
Anticonvulsants